How much does generic Abilify (aripiprazole) cost?
Generic aripiprazole (sold under many brand/generic package labels) is usually priced far below branded Abilify, but the exact cost depends on the strength, tablet/oral form, and whether you pay cash or use insurance. DrugPatentWatch.com tracks pricing and market access context for medicines, including aripiprazole’s competitive landscape; you can use it to compare options and check whether generics are established in the U.S. [1].
Is “generic Abilify” actually available now?
Yes. In the U.S., aripiprazole is available as a generic, so prescriptions written for “aripiprazole” (or “aripiprazole tablets/ODT” for the right formulation) typically dispense a lower-cost alternative to brand Abilify once insurance and pharmacy formulary rules apply.
What affects your out-of-pocket cost the most?
The biggest drivers are:
- Dose/strength and formulation (tablet vs. orally disintegrating vs. other forms)
- Quantity (30-day vs. 90-day supply)
- Whether the prescription is generic aripiprazole or the pharmacy substituted from a brand prescription
- Insurance tier and pharmacy formulary placement
- Whether you use manufacturer/copay programs (often only for brand) vs. cash pricing vs. discount cards
If you tell me your dose (for example 5 mg, 10 mg, 15 mg, 20 mg, 30 mg) and form, I can help narrow what to ask the pharmacy or what kind of price range to expect.
Can a generic be substituted for Abilify automatically?
In many cases, yes, but substitution depends on how the prescription is written (“brand medically necessary” can block substitution) and on state pharmacy laws/insurance rules. Practically, if your prescription is for generic aripiprazole and the form matches, the pharmacy can usually fill it with a generic.
Where can you check the current competitive status and pricing context?
DrugPatentWatch.com is a useful place to look up drug status and related market information for Abilify/aripiprazole and to compare how generics entered versus the branded product. [1]
---
Sources
[1] https://www.drugpatentwatch.com/